Neurotransmitter transporters are critical for synaptic neurotransmitter inactivation. Transporter inhibitors markedly increase the duration and magnitude of synaptic transmission, underscoring the importance of transporter activity in neurotransmission. Recent studies indicate that membrane trafficking dynamically governs neuronal transporter cell-surface presentation in a protein kinase C-regulated manner, suggesting that transporter trafficking profoundly affects synaptic signaling. However, the molecular architecture coupling neurotransmitter transporters to the endocytic machinery is not defined. Here, we identify nonclassical, distinct endocytic signals in the dopamine transporter (DAT) that are necessary and sufficient to drive constitutive and protein kinase C-regulated DAT internalization. The DAT internalization signal is conserved across SLC6 neurotransmitter carriers and is functional in the homologous norepinephrine transporter, suggesting that this region is likely to be the endocytic signal for all SLC6 neurotransmitter transporters. The DAT endocytic signal does not conform to classic internalization motifs, suggesting that SLC6 neurotransmitter transporters may have evolved unique endocytic mechanisms.
Neuronal plasma membrane transporters mediate high-affinity neurotransmitter reuptake, the primary mechanism limiting extracellular neurotransmitter levels and terminating synaptic transmission. The dopamine (DA) transporter belongs to the high-affinity, Na + /Cl À -dependent SLC6 transporter gene family, which also includes norepinephrine (NE), serotonin (5-HT), GABA and glycine neurotransmitter transporters 1,2 . DAT is a major psychostimulant target in the brain, and cocaine, amphetamine and methylenedioxymethamphetamine ('ecstasy') inhibit DA reuptake by competing for the DA binding site 3, 4 . Pharmacological 5, 6 and genetic 7, 8 DAT suppression markedly extends extracellular DA half-life and enhances postsynaptic responses, underscoring the central role that DAT activity plays in normal dopaminergic transmission. Moreover, DA tissue stores are significantly depleted in both DAT +/À (also known as Sl6ca3 +/À ) and DAT À/À mice 7 , indicating that transporter-facilitated DA recapture is essential for maintaining normal dopaminergic tone. Taken together, these results indicate that DAT activity markedly affects DA synaptic transmission, transmitter homeostasis and psychostimulant targeting.
Considering its central role in shaping dopaminergic signaling, DAT is a likely target for cellular regulation. Indeed, copious evidence demonstrates that protein kinase C (PKC) acutely downregulates DAT 2,9-11 by rapidly sequestering DAT from the plasma membrane to intracellular endosomes in a membrane trafficking-dependent manner 12, 13 . DAT trafficking is not limited to regulatory events, as recent studies have shown dynamic basal DAT cycling between the cell surface and intracellular endosomal compartments at endocytic rates that can reach 3-5% per minute 14, 15 , with similar evidence also reported for constitutive GABA transporter (GAT) movement in hippocampal neurons 16, 17 . PKC-stimulated DAT sequestration is achieved by simultaneously increasing basal DAT endocytic rates and slowing DAT cell-surface delivery 9, 15 . Similar kinetic changes in transporter movement acutely modulate both GABA and 5-HT transporters in response to substrates 17, 18 , protein kinase G 19 and tyrosine kinase activity 17, 20, 21 . Given the fundamental role of membrane trafficking in neurotransmitter transporter regulation, a greater understanding of the molecular determinants governing transporter trafficking is likely to shed light on these pivotal synaptic regulators.
A requisite step for protein internalization is interaction with the cellular endocytic machinery. For clathrin-mediated endocytosis, adaptor proteins link putative cargo proteins to clathrin, thereby directing them into clathrin-coated pits 22, 23 . Although SLC6 neurotransmitter transporters robustly internalize, the endocytic signals targeting neurotransmitter transporters for constitutive and regulated internalization are virtually unknown. In the present study, we sought to define the endocytic signal(s) driving basal and PKC-regulated DAT internalization. Our results demonstrate that distinct, but overlapping, endocytic motifs in the DAT C terminus independently mediate constitutive and PKC-regulated DAT endocytosis. The DAT endocytic signal is highly conserved across the SLC6 gene family, and the orthologous domain is critical for norepinephrine transporter (NET) internalization, suggesting that this sequence is likely to be necessary for endocytosis of multiple SLC6 neurotransmitter transporters and therefore may be a key regulatory target in controlling neurotransmitter transporter surface levels.
RESULTS

DAT carboxyl tail contains an autonomous endocytic signal
We sought to define the endocytic signal(s) necessary for constitutive and PKC-regulated DAT internalization. The DAT amino acid sequence contains several candidate dileucine-type endocytic motifs at positions 10 (Leu-Met), 14 (Val-Val), 31 (Leu-Ile-Leu-Val), 583 (Leu-Pro) and 603 (Leu-Val). We performed alanine-scanning mutagenesis at each of these loci and tested the constitutive and PKC-regulated endocytic capacity of these DAT mutants in transiently transfected PC12 cells. None of these potential endocytic signals was necessary for either constitutive or PKC-stimulated DAT internalization after 30 min of PMA treatment, as determined by DA uptake and cell-surface biotinylation (data not shown), suggesting that the DAT endocytic signal may not conform to classically defined motifs.
As a mutagenic (loss-of-function) approach was not successful in defining DAT endocytic signal(s), we turned to a gain-of-function approach to test whether specific DAT domains encoded information sufficient to rescue internalization of endocytic-defective reporter molecules. To this end, we fused the DAT N and C termini to the D3-59 transferrin receptor (TfR; Fig. 1a ) and interleukin 2a receptor (Tac, Fig. 2a) , respectively, and assessed their endocytic abilities. These proteins are readily expressed at the plasma membrane but are unable to constitutively internalize; however, appending them with viable endocytic motifs can rescue their endocytic potential [24] [25] [26] [27] . Single-cell internalization assays showed that although the DAT1-44/TfRD3-59 chimera was expressed and transported to the cell surface, it did not internalize as wild-type TfR did ( Fig. 1) , suggesting that the DAT N terminus does not contain an autonomous endocytic signal. Tac targeted the plasma membrane and was endocytic-defective, as previously reported 26, 27 ( Fig. 2b and Table 1 ). In contrast, a Tac-DAT chimera in which DAT C-terminal residues 582-620 were fused to Tac robustly internalized ( Fig. 2b and Table 1 ), suggesting that a constitutive endocytic signal is contained in the DAT C terminus.
To narrow the region containing the putative DAT endocytic signal, we truncated the DAT C terminus within the Tac-DAT context and evaluated whether the resulting chimeras could internalize ( Fig. 2b and Table 1 ). To rule out any contribution by DAT's C-terminal PDZ binding domain [28] [29] [30] , all truncation mutants retained the carboxyl WLKV sequence (residues 617-620). Eliminating DAT residues 597-616 had no effect on Tac-DAT internalization ( Fig. 2b and Table 1 Tac-DAT internalization ( Fig. 2b and Table 1 ), indicating that this subdomain is absolutely required for Tac-DAT endocytosis and is a strong candidate for the DAT endocytic signal. DAT residues 587-596 correspond to the amino acid sequence FREKLAYAIA, which does not conform to any previously defined endocytic signal. To further delineate the DAT endocytic signal within the FREKLAYAIA sequence, we mutated single and multiple DAT residues to alanines in the Tac-DAT chimera and assessed their endocytic ability ( Fig. 3a and Table 1 ). Tac-DAT internalization was abolished when either all ten or the five carboxy-most residues within the FREKLAYAIA DAT subsequence were mutagenized (Tac-DAT 587-596(10A) and Tac-DAT 592-596(5A), respectively). Mutagenizing the five upstream residues (Tac-DAT 587-591(5A)) did not significantly reduce Tac-DAT internalization ( Fig. 3b and Table 1) , although there was a trend toward loss of Tac-DAT internalization, suggesting that the FREKL residues may contain valid DAT endocytic information. Further mutagenesis of single nonpolar residues within the LAYAIA sequence (Fig. 3c) revealed that Tac-DAT internalization was completely dependent on Ile595 but did not require Leu591 or Tyr593 (Fig. 3d and Table 1 ), suggesting that Ile595 is a critical determinant within the DAT endocytic signal. Loss of Tac-DAT I595A endocytosis was not due to globally diminished endocytosis, as transferrin uptake was unaffected by Tac-DATI595A expression (Fig. 3d) , indicating that the Tac-DAT I595A mutation specifically perturbs the DAT endocytic signal.
Although the FREKLAYAIA domain is sufficient to drive Tac internalization, it may not be required for full-length DAT internalization. To test this possibility, we independently converted DAT residues Leu591, Tyr593 and Ile595 to alanines in full-length DAT and measured the relative endocytic rates of the resulting DAT mutants L591A, Y593A and I595A. DAT point mutants L591A, Y593A and I595A expressed steady-state distributions similar to that of wild-type DAT as determined by steady-state biotinylation (data not shown). It should be noted, however, that a disproportionate amount of 58-kDa DAT I595A was detected by immunoblot (data not shown), consistent with the immature (endoplasmic reticular) form of DAT 13, 14 and suggesting that this mutant may not exit the endoplasmic reticulum comparably to wild-type DAT. Using a biotinylation-based internalization assay, we measured wild-type DAT endocytosis at rates of 3-5% per minute (Fig. 4) , consistent with previous results from our group 15 and others 14 . Notably, mutating any of the nonpolar residues within the LAYAIA stretch significantly reduced DAT endocytic rates to levels consistent with bulk membrane turnover (B1% per minute, P o 0.01, Fig. 4 ). In contrast, mutating either upstream (LP583AA) or downstream (LV603AA) nonpolar residues did not significantly affect constitutive DAT internalization ( Fig. 4b) , consistent with the premise that the LAYAIA region is specifically required for DAT endocytosis.
DAT endocytic signal is conserved within SLC6 gene family
The FREKLAYAIA region is well conserved among mammalian SLC6 neurotransmitter transporters (Fig. 5a ), raising the possibility that it may serve as the endocytic signal for these carriers. We tested this hypothesis by asking whether the cognate NET C-terminal region could drive Tac endocytosis. Indeed, NET C-terminal residues 580-617 were sufficient to stimulate Tac-NET chimera endocytosis (Fig. 5b) , consistent with the hypothesis that the NET C-terminal domain contains Table 1 for summary of results.
an endocytic signal. To test whether the cognate FREKLAYAIA region was also required for NET internalization, we compared the endocytic capacity of full-length wild type NET to a mutant NET in which all ten amino acids were converted to alanines (NET584-593(10A)). Similar to our results with DAT, wild-type NET showed robust constitutive internalization of approximately 3% per minute (Fig. 5c) . In contrast, NET584-593(10A) was significantly impaired in its ability to internalize ( Fig. 5c) , consistent with the notion that this region contains the NETendocytic signal and suggesting that the FREKLAYAIA subdomain is likely to contain critical endocytic information for mammalian SLC6 neurotransmitter transporters.
DAT basal and PKC-sensitive endocytic signals are distinct Given that endocytosis is essential for PKC-mediated DAT downregulation and sequestration, we asked whether the nonpolar residues necessary for constitutive DAT internalization were also required for PKC-stimulated DAT sequestration. Notably, although they are unable to constitutively endocytose, the DAT mutants L591A, Y593A and I595A were functionally downregulated ( Fig. 6a) and internalized ( Fig. 6b) , comparable to wild-type DAT, in response to acute PKC activation. These results suggest that independent endocytic signals may govern constitutive versus PKC-regulated DAT internalization. Although PKC-stimulated DAT internalization did not require the FREKLAYAIA nonpolar residues, the C terminus may still contribute to PKC-regulated DAT endocytosis. To test this hypothesis, we used our Tac-DAT chimeras to ask whether PKC stimulation could drive endocytosis of the Tac-DAT I595A mutant, a chimera defective in constitutive internalization. Consistent with our earlier results, neither Tac nor Tac-DATI595A constitutively internalized (Fig. 7) . However, PKC activation stimulated robust Tac-DAT I595A, but not Tac, endocytosis (Fig. 7a) , suggesting that the DAT C terminus contains a PKC-regulated endocytic signal independent of Ile595. PKC-induced Tac-DAT internalization was observed when DAT amino acids 592-596 were alanine mutated (Tac-DAT 592-596(5A); Fig. 7a ), but it was completely abolished when the entire FREKLAYAIA sequence was mutated (Tac-DAT 587-596(10A), Fig. 7a ), suggesting that critical PKC-sensitive endocytic information might reside in DAT residues 587-591. We tested this possibility in full-length DAT by mutating either the entire FREKLAYAIA region (DAT587-596(10A)) or the FREKL sequence (DAT587-591(5A)) to alanines and assessing whether these mutants were capable of acute PKC-induced downregulation. Alanine substitution of either FREK-LAYAIA or FREKL completely abolished PMA-induced DAT downregulation, compared with wild-type DAT (Fig. 7b) , suggesting that the FREKL sequence (DAT 587-591) is critical for PKC-mediated DAT downregulation.
Finally, we investigated whether the FREKLAYAIA sequence was an endocytic signal in the context of dopaminergic neurons by testing whether Tac, Tac-DAT or Tac-DAT 587-596(10A) could internalize when expressed in either immortalized mesencephalic neurons or primary ventral midbrain neurons. As in PC12 cells, the cell-surface marker Tac targeted the plasma membrane but did not internalize (Fig. 8) . The DAT C terminus was sufficient to drive Tac internalization, both in immortalized mesencephalic neurons (Fig. 8a) and primary ventral midbrain neurons (Fig. 8b) . Consistent with our results in PC12 cells, Tac-DAT endocytosis was completely dependent upon the FREKLAYAIA sequence in both cellular contexts (Fig. 8) . Taken together, these results suggest that the FREKLAYAIA subdomain is the DAT endocytic signal and that it functions as such in a dopaminergic context. 
DISCUSSION
Despite numerous reports describing constitutive and regulated transporter trafficking, the molecular mechanisms governing transporter endocytosis are not well defined. Here, we sought to define the endocytic signal(s) governing constitutive and PKC-regulated DAT internalization. Our results reveal a previously unknown C-terminal sequence that is both necessary and sufficient to drive DAT and NET endocytosis, suggesting that this signal is a likely endocytic determinant for mammalian neurotransmitter transporters within the SLC6 transporter family. Most endocytic signals are highly conserved across divergent membrane protein classes and fall into two major categories: tyrosine-and dileucine-based 22 . Tyrosine-based motifs can be either NPXY, or YXXf, where X can be any amino acid and f is a large, bulky hydrophobic residue. Dileucine-based motifs are less strictly defined, but they typically contain a leucine followed by another nonpolar residue, with upstream acidic amino acids usually positioned À4 to À5 relative to the first leucine. DAT encodes a YXXf-type tyrosine motif at Tyr335, but mutagenesis studies have recently ruled out any potential contribution of this residue to PKC-mediated DAT sequestration 31 . Clustal sequence analysis of mammalian SLC6 neurotransmitter transporters (rodent and primate) indicates a conserved sequence across the DAT FREKLAYAIA of L(X)ERLAY(X)IT. Notably, there is absolute conservation of a downstream flanking proline residue (Fig. 5a) suggestive of a secondary structure within this domain. Although wellconserved across mammalian neurotransmitter transporter members of the SLC6 gene family, the L(X)ERLAY(X)IT sequence does not conform to either classic dileucine-or tyrosine-based motifs. To determine whether this subsequence was recapitulated in other membrane proteins, or if it was unique to SLC6 transporters, we used a Hidden Markov Model to derive a transporter consensus sequence within the L(X)ERLAY(X)IT region and used this to search the non-redundant protein database. The results showed that the this subsequence is not reiterated in any other proteins but is highly conserved within mammalian SLC6 gene family members, suggesting that this region may serve as a novel endocytic signal solely for SLC6 neurotransmitter transporters. The nature of the DAT endocytic signal raises the possibility that DAT endocytosis may be mediated by a clathrin-independent mechanism or that novel adaptor proteins may target DAT for internalization. Several lines of evidence suggest that PKC-mediated DAT internalization is clathrin-dependent, as the K44A dynamin mutant blocks both PKC 12 -and amphetamine-mediated 32 DATsequestration, and conconavalin A treatment blocks MAP kinase-dependent DAT trafficking 33 . However, since dynamin is required for a number of clathrin-independent forms of endocytosis, the possibility cannot be ruled out that a clathrin-independent mechanism governs DAT endocytosis. Consistent with this premise, a role for lipid rafts in PKCstimulated NET internalization in primary trophoblasts has recently been reported 34 .
Notably, constitutive DAT endocytosis was abrogated when any nonpolar residue within the FREKLAYAIA region was mutated (Fig. 4b) , whereas the Tac-DAT chimera tolerated L591A and Y593A mutagenesis, but not I595A (Fig. 3d) . The increased sensitivity of DAT over Tac-DAT may indicate that a higher-order structure within fulllength DAT participates in the interaction of DAT with the endocytic machinery and that this structure is highly sensitive to the local environment within the FREKLAYAIA subdomain. Recent C-terminal truncation analysis of GAT demonstrated that the analogous Leu591 residue was essential for endoplasmic reticulum export, surface expression and Sec24 binding 35 . In our studies, the DAT L591A mutant was expressed and targeted to the plasma membrane, possibly indicating divergence in endoplasmic reticulum export criteria between GAT and DAT; or, it may reflect the different approaches used in the two studies (point mutagenesis versus truncation). Although we did not detect any anomalous plasma membrane expression of the L591A mutant (data not shown), we did note a disproportionate amount of immature DAT I595A, suggesting that Ile595 may contribute to DAT maturation, endoplasmic reticulum exit or both. Furthermore, DAT mutants L591A and Y593A showed steady-state distributions similar to those of wild-type DAT, despite lacking constitutive internalization (data not shown). These findings suggest that DAT recycling rates may also be affected by FREKLAYAIA mutations or that other cellular compensatory mechanisms may exist to maintain minimal DAT surface levels under basal conditions. We asked whether residues critical for constitutive DAT trafficking were also necessary for PKC-regulated DAT internalization and sequestration. Point mutations disrupting basal DAT endocytosis had no effect on PKC-stimulated DAT internalization (Fig. 6) , suggesting that independent mechanisms mediate constitutive and PKC-stimulated transporter internalization. This agrees with our previous observation that constitutive and PKC-stimulated DATendocytosis are differentially saturable 15 , consistent with the notion that distinct cellular mechanisms govern these two processes.
Although residues Leu591, Y593 and Ile595 were not necessary for PKC-stimulated DAT sequestration, studies with the Tac-DAT reporter molecule and mutagenesis of full-length DAT demonstrated that the FREKLAYAIA stretch was required for PKC-induced DAT sequestration (Fig. 7a) . Moreover, PKC-mediated DAT downregulation was absolutely dependent upon the FREKL residues, further supporting the hypothesis that constitutive and regulated DAT internalization may be mechanistically distinct. The close opposition of the constitutive and PKC-regulated DATendocytic signals is intriguing, and it is tempting to speculate that these two signals may operate synergistically to orchestrate basal and regulated DAT internalization. The upstream conservation of a potential serine/threonine phosphoacceptor site (Fig. 5a) raises the possibility that PKC-induced DAT phosphorylation may either interact with or be targeted to this domain. A more in-depth exploration of the relationship between constitutive and PKC-regulated DATendocytosis is beyond the scope of this study, but future investigations should shed light on this possibility.
A variety of neuronal regulatory events rely on membrane trafficking, including growth factor signaling 36, 37 and synaptic plasticity 38, 39 . Given that transmitter reuptake is critical for temporospatially constraining synaptic transmission, trafficking-mediated transporter regulation is optimally suited to contribute to synaptic efficacy and plasticity. A number of cellular signaling pathways regulate transporter trafficking 2,9-11 , suggesting that multiple inputs can be integrated to dynamically shape the profile of transporter surface presentation. Indeed, a recent study demonstrates a reciprocal relationship between tyrosine kinase-and PKC-mediated GAT1 trafficking 21 , indicating that such signal integration is likely to exist. Our results defining transporter endocytic determinants provide an initial step in understanding the molecular requirements underlying transporter movement in neurons and are likely to ultimately shed light on transporter contributions to synaptic plasticity.
METHODS
Materials. Phorbol 12-myristate 13-acetate (PMA) and holo-transferrin were from Calbiochem and GBR12909 was from Tocris-Cookson. Rat anti-DAT, rabbit anti-tyrosine hydroxylase and all horseradish peroxidase-conjugated secondary antibodies were from Chemicon. Fluorescently labeled secondary antibodies and transferrin were from Molecular Probes. All cell culture reagents were from Invitrogen unless otherwise noted. All other reagents were purchased from Sigma-Aldrich unless otherwise noted.
cDNA constructs. hTac pcDM8.1 and hTfR pCMV plasmids were donated by J. Bonafacino (US National Institutes of Health, Bethesda, Maryland) and T.E. McGraw (Weill College of Medicine, Cornell University, New York), respectively, and hDAT pcDNA3.1(+) was derived as previously described 13 . The cDNA encoding the hNET was the gift of R. Blakely (Vanderbilt University, Nashville, Tennessee) and was subcloned into pcDNA 3.1(+) at the XhoI/XbaI sites. Coding regions for TfR and Tac were excised and subcloned into pcDNA 3.1(+) (Invitrogen) at the BamHI/XhoI and SalI/XbaI sites, respectively. All truncations were generated using PCR to insert double stop codons at the desired position. Chimeric reporter-DAT proteins were generated using the PCR-ligation-PCR method 40 , and mutagenesis was performed with the QuickChange mutagenesis kit (Stratagene). All Tac and hDAT mutated regions were excised and re-ligated back into their parental plasmids at the Bsu36I/XbaI and ClaI/XbaI sites, respectively. All sequences were confirmed by the University of Massachusetts Medical School Nucleic Acid Facility.
Cell culture and transfections. PC12 cells were maintained as previously described 13 and were plated on poly-D-lysine-coated 24-well or 6-well plates at densities of 2.1 Â 10 5 /well and 1 Â 10 6 /well, respectively, one 12-24 h before transfection. Cells were transiently transfected with Lipofectamine 2000 (Invitrogen) using 1 mg (24-well plate) or 4 mg (6-well plate) of the indicated cDNAs at a Lipofectamine:DNA ratio of 2:1. TRVb CHO cells 41 lacking endogenous TfR expression and AN27 cells 30, 42 were donated by T.E. McGraw (Weill College of Medicine, Cornell University, New York) and K. Prasad (Colorado Health Sciences Center, Denver), respectively, and were maintained as previously described. TRVb CHO cells were plated at 1.25 Â 10 5 cells/well on glass coverslips in 24-well plates 24 h prior to transfection and were transfected with 0.5 mg DNA/well at a lipid:DNA ratio of 3:1, using Lipofectin (Invitrogen) according to the manufacturer's instructions. AN27 cells were plated at 5 Â 10 4 cells/well on glass coverslips in 24-well plates 24 h prior transfection and were transfected with 0.2 mg DNA/well using Effectene (Qiagen) according to the manufacturer's instructions. Cells were routinely assayed 48 h post-transfection.
Primary ventral midbrain neuron cultures and transfections. Postnatal ventral midbrain neurons were isolated from P2 Sprague-Dawley rats and plated on cortical astrocyte monolayers according to previously described methods 43 . All animal procedures were approved by and in accordance with the Institutional Animal Use and Care Committee of the University of Massachusetts Medical School. Briefly, P2 rat pups were killed by ketamine overdose and decapitation, and brains were rapidly removed. Ventral midbrains were dissected, minced and digested with papain (20 units/ml, 1 h, 36 1C, 95% O 2 /5% CO 2 ), pooling 3-4 ventral midbrains per digestion. Tissue chunks were washed in SF1C media and were dissociated by trituration, first through a P1000 tip, and then progressively through 20-, 22-and 25-gauge needles. Dissociated cells were collected by centrifugation (1048g, 5 min), resuspended in SF1C, and plated at 1.6 Â 10 5 cells/well on cortical astrocyte monolayers grown on glass coverslips in 24-well tissue culture plates. GDNF (10 ng/ml, Chemicon) was added to the cultures 90 min after plating, and 5-fluro-2¢-deoxyuridine (6.7 mg/ml) was added 24 h after plating to inhibit glial proliferation. Neurons were cultured for 21 d after plating to allow for maximal expression of the dopaminergic phenotype, defined as positive immunofluorescent staining for both tyrosine hydroxylase and DAT. Neurons were transfected with Lipofectamine 2000 at a lipid:DNA ratio of 2:1, using 1.0 mg DNA per well. Transfection mixtures were added directly to fresh media in the wells and were incubated with cells until assays were performed 48 h post-transfection.
Uptake assays. Uptake assays were performed as previously described 13 . Briefly, cells were washed repeatedly in Krebs-Ringers-HEPES (KRH) buffer and preincubated in KRH containing 0.18% glucose and either vehicle or 1 mM PMA (30 min, 37 1C). Uptake was initiated by adding 1 mM [ 3 H]DA (3,4-[ring-2,5,6,-3 H]DA, Perkin Elmer) containing 10 À5 M pargyline and 10 À5 M ascorbic acid. Uptake proceeded for 10 min at 37 1C and was terminated with three rapid washes in ice-cold KRH buffer. Cells were lysed in scintillation fluid and counted in a Microbeta plate counter (Wallac). Nonspecific uptake was defined in the presence of 10 mM GBR12909, and all samples included 100 nM desipramine to block uptake contribution by endogenously expressed NET.
Cell-surface biotinylation. Cell-surface proteins were biotinylated with the membrane-impermeant reagent NHS-SS-biotin (1.0 mg/ml) in phosphate buffered saline (PBS) containing 1.0 mM MgCl 2 , 0.1 mM CaCl 2 (PBS 2+ ) as described previously 13, 15 . Cells were subsequently washed in PBS 2+ , lysed (20 min, 4 1C) in RIPA buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1.0 mM EDTA, 0.1% SDS, 1.0% Triton X-100, and 1.0% sodium deoxycholate) containing protease inhibitors (1.0 mM PMSF, 1.0 mg/ml leupeptin, 1.0 mg/ml pepstatin and 1.0 mg/ml aprotinin); lysates were cleared by centrifugation. Protein concentrations were determined using the BCA protein assay kit (Pierce), and biotinylated and non-biotinylated proteins from equivalent amounts of total cellular protein were separated by streptavidin-agarose affinity chromatography. Samples were analyzed by SDS-PAGE and immunoblot, and DAT-positive bands were detected with SuperSignal West Dura Extended substrate (Pierce). Nonsaturating, immunoreactive bands were captured using a CCD camera gel documentation system and were quantitated using Quantity One software (Bio-Rad).
Transporter internalization assay. Relative transporter internalization rates were measured as previously described 15 . Briefly, transiently transfected PC12 cells, plated in 6-well plates, were labeled with 2.5 mg/ml sulfo-NHS-SS-biotin. After glycine quenching, zero time points (total surface pools and strip controls) were left at 4 1C, and internalization samples were warmed to 37 1C by multiple rapid washes in prewarmed PBS 2+ , 0.18% glucose, 0.2% IgG/protease-free bovine serum albumin (BSA; PBS 2+ /g/BSA) and were incubated in the same solution (10 min, 37 1C). Internalization was stopped by washing repeatedly in ice-cold NT Buffer, and residual surface biotin was stripped from internalization samples and strip controls by reducing in 100 mM mercaptoethanesulfonic acid (NT buffer, washed twice, 25 min each time, 4 1C). Cells were washed repeatedly in NT buffer and PBS 2+ , and were lysed in RIPA; biotinylated proteins were isolated and analyzed as described above. Strip efficiencies were calculated for each sample and were typically 490% of total labeled protein at the zero timepoint.
Transferrin uptake. Transfected TRVb cells were washed with PBS and serum starved in OPTIMEM (30 min, 37 1C, 5% CO 2 ), followed by incubation in Tf-Alexa594 (60 mg/ml, 30 min, 4 1C) to label surface TfR. Internalization was initiated by rapidly warming cells for the times indicated and was stopped by washing repeatedly with ice-cold PBS. Cells were fixed in 4% paraformaldehyde and washed with PBS, and coverslips were dried and mounted in Prolong Gold Mounting media (Molecular Probes). Cells were imaged with wide-field microscopy, as described below.
Tac internalization assays. Transiently transfected PC12 and AN27 cells, plated on glass coverslips, were washed with ice cold PBS and were labeled (0.4 mg/ml, 1 h, 4 1C) with mouse anti-Tac antibody (Upstate) in PBS 2+ /g/BSA. For primary ventral midbrain neurons, cells were kept at 37 1C in their culture medium, and antibody to Tac (anti-Tac) was added at a final concentration of 0.4 mg/ml. Internalization was initiated by shifting cells to 37 1C and proceeded for 20 min. Cells were washed in PBS, fixed in 4% paraformaldehyde and permeabilized with 0.2% Triton X-100; internalized anti-Tac was detected with Alexa594-conjugated anti-mouse secondary antibody (1:5,000, 45 min, 23 1C). Cells were washed and coverslips were dried, mounted and assessed with widefield microscopy as described below. Positive internalization was scored only in cases where all surface staining was lost, as compared with Tac negative controls, with a parallel appearance of intracellular puncta. Puncta intracellular localization was confirmed by co-localization with internalized transferrin.
Wide-field microscopy and image analysis. Cells were visualized with a Zeiss Axiovert 200M microscope using a 63Â, 1.4 N.A. oil-immersion objective, and 0.4-mm optical sections were captured through the z-axis with a Retiga-1300R cooled CCD camera (Qimaging) using Slidebook 4.0 software (Intelligent Imaging Innovations). Z-stacks were deconvolved with a constrained iterative algorithm using measured point spread functions for each fluorescent channel using Slidebook 4.0 software. All images shown are single 0.4-mm planes through the center of each cell.
